Not available
Quote | Marine Petroleum Trust Units of Beneficial Interest (NASDAQ:MARPS)
Last: | $3.9199 |
---|---|
Change Percent: | 0.61% |
Open: | $3.906 |
Close: | $3.9199 |
High: | $3.9199 |
Low: | $3.9 |
Volume: | 1,428 |
Last Trade Date Time: | 06/25/2024 03:00:00 am |
News | Marine Petroleum Trust Units of Beneficial Interest (NASDAQ:MARPS)
2024-05-21 14:00:47 ET More on Energy Select Sector SPDR ETF LNG Exports And Natural Gas Dynamics XLE: Double Digit Dividend Growth Should Be Sustainable Transitioning: Mining, Minerals And Sustainable Developments Read the full article on Seeking Alpha ...
2024-05-20 10:24:38 ET Marine Petroleum Trust ( NASDAQ: MARPS ) declares $0.0559/share quarterly dividend . Forward yield 5.02% Payable June 28; for shareholders of record May 31; ex-div May 31. See MARPS Dividend Scorecard, Yield Chart, & Dividend Growth...
Message Board Posts | Marine Petroleum Trust Units of Beneficial Interest (NASDAQ:MARPS)
Subject | By | Source | When |
---|---|---|---|
trending up | MouthBreather | investorshub | 06/09/2022 1:04:55 PM |
znewcar1: MARPS 27% v1,1M c9.61 ML6.88 Hod10.74 | znewcar1 | investorshangout | 04/14/2022 10:31:27 PM |
znewcar1: MARPS 21% v1,1M c13.93 f2,0M H15.25 | znewcar1 | investorshangout | 03/17/2022 11:00:18 PM |
Royalty interest in 55 oil & natural gas | Jack_Bauer_Investing | investorshub | 03/15/2022 3:47:51 PM |
znewcar1: MARPS 27% v8,3M H15.49 f2,0M H32.00 S@11 | znewcar1 | investorshangout | 03/09/2022 3:33:45 AM |
News, Short Squeeze, Breakout and More Instantly...
Marine Petroleum Trust Units of Beneficial Interest Company Name:
MARPS Stock Symbol:
NASDAQ Market:
ESSA Pharma Inc. (EPIX) is expected to report $-0.17 for Q1 2024 QuidelOrtho Corp Com (QDEL) is expected to report $2.01 for Q4 2023 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 Portsmouth Square, Inc. (PRSI) is expected to report for Q2 2024 Similarweb Ltd. (SMWB) ...
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
QualTek Services Inc. (QTEKQ) is expected to report for Q2 2023 Amerityre Corp (AMTY) is expected to report for quarter end 2023-06-30 BYD Co - Class H (BYDDF) is expected to report for quarter end 2023-06-30 Shionogi & Co. Ltd. ADR (SGIOY) is expected to report for Q1 2024 Ea...